Mar 31, 2014
Dear Members,
The Directors have the pleasure in presenting their 28th Annual Report
and audited Accounts of your Company, for the year ended 31st March,
2014.
FINANCIAL RESULTS :
2013-2014 2012-2013
(Rs. in Lacs) (Rs. in Lacs)
Earnings before Interest,
Depreciation & Tax (EBITDA) 47.30 62.39
Less: Bank Charges and Interest 8.41 20.21
Depreciation 26.24 26.19
Profit before Taxation 12.65 15.99
Less/ (Add): Provision for Current Tax 2.29 2.97
Provision for Deferred Tax 3.71 5.04
Profit after Taxation 6.65 7.98
OPERATIONS :
1) During the year under review, the Government of India finally
notified the Drugs Price Control Order 2013 in May-2013 regulating the
Prices of 348 essential medicines covered under the National List of
Essential Medicines. The order was made effective from 1st July 2013.
like most of the Companies in Pharmaceutical Industry, your company was
also affected by the DPCO 2013, since more than dozen of the companies
products came under price control, with the reduction in prices ranging
from 20% to 40%. Further the stockiest and retailers refused to lift
the goods from all companies until
a) The new prices were announced
b) The Goods with new prices were supplied to them
Further stand taken by the stockiest of getting the old margins for
newly covered price controlled items also affected the Sales during the
year under review. Inspite of all these hurdles your Company maintained
top line, though the bottom line was affected by the compressed
margins.
The total revenues of the company stood at Rs.792 lacs compared to
Rs.779 lacs of previous financial year, an increase of 2 %.
The earnings before Interest, Depreciation and tax, was also lower at
Rs. 47.30 Lacs during the year under review compared to Rs. 62.39 Lacs
in the previous year. The profit before tax was Rs. 12.65 Lacs , the
net profit after providing for Income Tax and Deferred Tax Liability
was Rs. 6.65 Lacs . Net profit would have been higher except for
increase in the staff cost particularly incurred to retain the
productive field staff and the increase in Material Cost.
DIVIDEND :
Your Directors are unable to recommend any dividend during the year
under review, considering the small surplus available and with a view
to conserve funds towards margin monies.
LISTING OF SHARES:
The shares of your Company are listed in Stock Exchange, Mumbai. Annual
Listing Fees for the year 2013-14 has been paid on time.
PUBLIC DEPOSITS :
The Company has not invited / received any fixed deposits during the
year.
DIRECTORS:
The Board consists of Executive and Non-Executive directors, including
independent Directors, who have wide and varied experience in different
disciplines of corporate functioning. In accordance with the provisions
of Companies Act, 2013, as amended from time to time and Article of
Association of the Company, Shri. A. Krishna Kumar who retires by
rotation at the ensuing Annual General Meeting and being eligible
offers himself for re-appointment.
COST AUDITORS''
Pursuant to the order issued by Central Government Under Section 233B
of the Companies Act 1956,
The Board of Directors of your Company have appointed MR. K. R.
Vaidyanathan Cost Accountants for conducting the Audit of Cost
Accounting records maintained by the Company for its formulations.
DIRECTORS'' RESPONSIBILITY STATEMENT:
In terms of provisions of Section 217[2AA] of the Companies Act, 1956,
your Directors confirm that:
I. In the preparation of the annual accounts, the applicable
accounting standards have been followed, along-with proper explanation
relating to material departures, wherever applicable.
II. The Directors have selected such accounting policies and applied
them consistently and made judgments and estimates that are reasonable
and prudent so as to give a true and fair view of the state of affairs
of the Company, as at the end of the accounting year and of the profit
of the company for that year;
III. The Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Act, as amended from time to time for safeguarding
the assets of the Company and for preventing and detecting fraud and
other irregularities;
IV. The Directors have prepared the annual accounts on a going concern
basis.
PERSONNEL:
During the year under review, relations between the Employees and the
Management remained cordial.
There are no employees falling within the provision of Section 217 (2A)
of the Companies Act, 1956, read with the Companies (Particulars of
Employees) Rules, 1975 as amended from time to time.
CONSERVATION OF ENERGY:
Except for the consumption of Power (Electricity) the Company does not
consume any other source of energy. Pharmaceutical company is not
power intensive. Since it also involves multiple products, disclosure
of consumption of power per unit of product is not meaningful.
TECHNOLOGY ABSORPTION, ADAPTATION AND INNOVATION:
No imported technology is adapted by the Company. Continuous
developmental efforts are made by our qualified and approved staff to
formulate new products and innovation of existing products. Such
efforts have benefited in improving the stability of our products and
simplification of manufacturing procedures.
FOREIGN EXCHANGE:
During the year under review, Foreign exchange earned Rs.Nil,( Previous
Year - Rs. NIL/-). Foreign exchange outgo was Rs. NIL, (Previous Year -
NIL /-).
RESEARCH AND DEVELOPMENT:
Your Company has not incurred any expenditure on research and
development other than the routine developmental work.
REPORT ON CORPORATE GOVERNANCE
Pursuant to Clause 49 of the Listing Agreement with the Stock Exchange,
the following form part of this Annual Report:
i) Management Discussion and Analysis.
ii) Report on Corporate Governance.
iii) Auditor''s Certificate regarding compliance of conditions of
Corporate Governance.
OTHER MATTERS:
Your Company is not a polluting industry and the requirements of
Pollution Control Board, if any, are met with.
AUDITORS:
M/s. S. V. Bhat & Co., Chartered Accountants, retire as auditors of the
Company at the conclusion of the 28th Annual General Meeting and are
eligible for reappointment.
ACKNOWLEDGEMENT:
Your Directors would like to acknowledge the co-operation they received
during the year under review from Bankers, Distributors as well as from
various Government Departments and also the investing public. We would
also like to place on record our profound admiration and sincere
appreciation of the hard work put in by the members of the staff and
workmen. We are grateful to you, for the confidence and faith you have
reposed in us.
For and on behalf of the Board
Dr. L. S. Mani
Chairman & Managing Director
Mumbai, 15th May, 2014
Mar 31, 2010
The Directors have the pleasure in presenting their 24th Annual Report
and audited Accounts of your Company, for the year ended 31st March,
2010.
FINANCIAL RESULTS:
2009-2010 2008-2009
(Rs. in Lacs) (Rs. in Lacs)
Earnings before Interest, Depreciation
& Tax (EBITDA) 49.99 56.29
Less: Bank Charges and Interest 17.68 23.86
Depreciation 25.70 26.24
Profit before Taxation 6.61 6.19
Less/ (Add): Provision for Current Tax 0.96 0.59
Provision for Deferred Tax (2.81) 3.28
Fringe Benefit Tax - 1.32
Profit after Taxation 8.46 1.00
OPERATIONS:
During the year under review, the total revenues of the company stood
at Rs.566.00 lacs compared to 549.00 lacs. The Profit before Tax was
Rs. 6.61 lacs.The net Profit after providing for income tax and
Deferred Tax was Rs.8.46 lacs. The earnings before Interest,
Depreciation and tax was lower at 49.99 lacs during the year under
review compared to Rs. 56.29 in the previous due to increase in the
employee cost, particularly incurred to retain the productive field
staff.
DIVIDEND:
Your Directors are unable to recommend any dividend during the year
under review, considering the small surplus available and with a view
to conserve funds towards margin monies.
LISTING OF SHARES:
The shares of your Company are listed in Stock Exchange, Mumbai. Annual
Listing Fees for the year 2010-11 has been paid on time.
PUBLIC DEPOSITS:
The Company has not invited / received any fixed deposits during the
year.
DIRECTORS:
The Board consists of Executive and Non-Executive directors, including
independent Directors, who have wide and varied experience in different
disciplines of corporate functioning. In accordance with the provisions
of Companies Act, 1956, and Article of Association of the Company, Shri
Krishnakumar Attrassary retires by rotation at the ensuring Annual
General Meeting and being eligible offers himself for re-appointment.
DIRECTORS RESPONSIBILITY STATEMENT:
In terms of provisions of Section 217[2AA] of the Companies Act, 1956,
your Directors confirm that:
I. In the preparation of the annual accounts, the applicable
accounting standards have been followed, along-with proper explanation
relating to material departures, wherever applicable.
II. The Directors have selected such accounting policies and applied
them consistently and made judgments and estimates that are reasonable
and prudent so as to give a true and fair view of the state of affairs
of the Company, as at the end of the accounting year and of the profit
of the company for that year;
III. The Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Companies Act, 1956 for safeguarding the assets of
the Company and for preventing and detecting fraud and other
irregularities;
IV. The Directors have prepared the annual accounts on a going concern
basis.
PERSONNEL:
During the year under review, relations between the Employees and the
Management remained cordial.
Particulars of employees as required under Section 217 (2A) of the
Companies Act, 1956, read with the Companies (Particulars of Employees)
Rules, 1975 as amended from time to time are not applicable to your
Company as there were no employees whose remuneration is in excess of
limits prescribed.
CONSERVATION OF ENERGY:
Except for the consumption of Power (Electricity) the Company does not
consume any other source of energy. Pharmaceutical company is not
power intensive. Since it also involves multiple products, disclosure
of consumption of power per unit of product is not meaningful.
TECHNOLOGY ABSORPTION, ADAPTATION AND INNOVATION:
No imported technology is adapted by the Company. Continuous
developmental efforts are made by our qualified and approved staff to
formulate new products and innovation of existing products. Such
efforts have benefited in improving the stability of our products and
simplification of manufacturing procedures.
FOREIGN EXCHANGE:
During the year under review, Foreign exchange earned Rs.Nil,( Previous
Year - Rs. NIL/-). Foreign exchange outgo was Rs. NIL, (Previous Year -
Rs. 1,17,024/-).
RESEARCH AND DEVELOPMENT:
Your Company has not incurred any expenditure on research and
development other than the routine developmental work.
REPORT ON CORPORATE GOVERNANCE
Pursuant to Clause 49 of the Listing Agreement with the Stock Exchange,
the following form part of this Annual
Report:
i) Management Discussion and Analysis.
ii) Report on Corporate Governance.
iii) Auditors Certificate regarding compliance of conditions of
Corporate Governance.
OTHER MATTERS:
Your Company is not a polluting industry and the requirements of
Pollution Control Board, if any, are met with.
AUDITORS:
M/s. S. V. Bhat & Co., Chartered Accountants, retire as auditors of the
Company at the conclusion of the 24th Annual General Meeting and are
eligible for reappointment.
ACKNOWLEDGEMENT:
Your Directors would like to acknowledge the co-operation they received
during the year under review from Bankers, Distributors as well as from
various Government Departments and also the investing public. We would
also like to place on record our profound admiration and sincere
appreciation of the hard work put in by the members of the staff and
workmen. We are grateful to you, for the confidence and faith you have
reposed in us.
For and on behalf of the Board.
Dr. L. S. Mani
Chairman & Managing Director
Mumbai, 29th May, 2010
Mar 31, 2009
The Directors have the pleasure in presenting their 23rd Annual Report
and audited Accounts of your Company, for the year ended 31st March,
2009
FINANCIAL RESULTS : 2008-2009 2007-2008
(Rs in Lacs) (Rs in Lacs)
Profit before Interest and Depreciation 56.29 54.70
Less: Bank Charges and Interest 23.86 28.53
Depreciation 26.24 23.95
Profit before Taxation 6.19 2.22
Less/(Add): Provision for Current Income Tax 0.59 0.23
Provision for Deferred Tax 3.28 (5.85)
Provision for Fringe Benefit Tax 1.32 1.25
Profit after Taxation 1.00 6.59
OPERATIONS:
During the year under review, the turnover of the company was Rs549
lacs compared to Rs 561 lacs in the previous year The Profit before Tax
wasRs619 lacs and the net Profit after provision for income Tax,
provision for FBT and provision for Deferred Tax was Rsl lac ,
The year 2008-09, saw the worst global financial and economic crisis
almost after 60 years The crisis had a severe knock-on effect on
developed as well as emerging economies This caused too much damage to
Indian economy also, compared to the stellar economic performance of
the immediate past years The degree of crisis was so severe that we saw
some of the worlds largest financial institutions collapsed and the
governments of some wealthiest nations in the world have resorted to
extensive bail outs and rescue packages It brought about the beginning
of a cyclical down turn in Indias economy and GDP growth, which was 9%
during 2007-08, compared to a growth of mere 58% in the third quarter
of 2008-09 Apart from the above, there was an impact of sharp increase
in the raw material prices of all imported bulk drugs and
intermediaries going into the manufacture of bulk drugs, due to the
government imposed shut down of plants in China, due to Olympic games
in the first half of the year under review This has affected the
margins of your Company apart from the abrupt depreciation of Indian
Rupee visavis other currencies, due to reversal of capital flow with
investors across the world withdrawing their investment in India, to
survive the severe crises in developed economies
Considering the credit crises, lower consumer spending, reduction in
corporate revenues and profits, lay offs, job cuts across the sectors,
across the globe including in India your Company was able to fair
reasonably well during the year under review in spite of higher
provision for depreciation and deferred tax
DIVIDEND:
Your Directors are unable to recommend any dividend during the year
under review, considering the small surplus available and with a view
to conserve funds towards margin monies
LISTING OF SHARES:
The shares of your Company are listed in Bombay Stock Exchange, Mumbai
Annual Listing Fees for the year 2009- 10 has been paid on time
PUBLIC DEPOSITS:
The Company has not invited / received any fixed deposits during the
year
DIRECTORS:
At the forthcoming Annual General Meeting MrVasant KBhat retires by
rotation and is eligible for reappointment Your Directors regret to
inform the untimely demise of Mr Michael DSouza; Advocate, on 30112008
Your Directors express their gratitude to the invaluable service
rendered by Late Mr Michael DSouza during his tenure as Director
Your Directors appointed Mr Krishnakumar Attrassary as Additional
Director (Independent) under section 260 of the Companies Act, 1956 to
fill the casual vacancy created on account of demise of Mr Michael
DSouza, who will hold office till the conclusion of the 23rd Annual
General Meeting
DIRECTORS RESPONSIBILITY STATEMENT:
In terms of provisions of Section 21712AA of the Companies Act, 1956,
your Directors confirm that:
I In the preparation of the annual accounts the applicable accounting
standards have been followed, along with proper explanation relating to
material departures, wherever applicable
II The Directors have selected such accounting policies and applied
them consistently and made judgments and estimates that are reasonable
and prudent so as to give a true and fair view of the state of affairs
of the Company, as at the end of the accounting year and of the profit
of the company for that year;
III The Directors had taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the
provisions of the Companies Act, 1956 for safeguarding the assets of
the Company and for preventing- and detecting fraud and other
irregularities;
IV The Directors have prepared the annual accounts on a going concern
basis
PERSONNEL:
During the year under review, relations between the Employees and the
Management remained cordial Particulars of employees as required under
Section 217 (2A) of the Companies Act, 1956, read with the Companies
(Particulars of Employees) Rules, 1975 as amended from time to time are
not applicable to your Company as there were no employees whose
remuneration is in excess of limits prescribed
CONSERVATION OF ENERGY:
Except for the consumption of Power (Electricity) the Company does not
consume any other source of energy Pharmaceutical company is not power
intensive Since it also involves multiple products, disclosure of
consumption of power per unit of product is not meaningful
TECHNOLOGY ABSORPTION, ADAPTATION AND INNOVATION:
No imported technology is adapted by the Company Continuous
developmental efforts are made by our qualified and approved staff to
formulate new products and innovation of existing products Such efforts
have benefited in improving the stability of our products and
simplification of manufacturing procedures
FOREIGN EXCHANGE:
During the year under review Foreign exchange earned RsNil,( Previous
Year- Rs NIL/-) Foreign exchange outgo was Rs 1,17,024/-( Previous
Year-Rs NIL/-)
RESEARCH AND DEVELOPMENT:
Your Company has not incurred any expenditure on research and
development other than the routine developmental work
REPORT ON CORPORATE GOVERNANCE
Pursuant to Clause 49 of the Listing Agreement with the Stock Exchange,
the following form part of this Annual Report:
i) Management Discussion and Analysis
ii) Report on Corporate Governance
iii) Auditors Certificate regarding compliance of conditions of
Corporate Governance
OTHER MATTERS:
Your Company is not a polluting industry and the requirements of
Pollution Control Board, if any, are met with
AUDITORS:
M/s S V Bhat & Co, Chartered Accountants, retire as auditors of the
Company at the conclusion of the 23rd , Annual General Meeting and are
eligible for reappointment
ACKNOWLEDGEMENT:
Your Directors would like to acknowledge the co-operation they received
during the year under review from Bankers, Distributors as well as from
various Government Departments and also the investing public We would
also like to place on record our profound admiration and sincere
appreciation of the hard work put in by the members of the staff and
workmen We are grateful to you, for the confidence and faith you have
reposed in us:
For and on behalf of the Board
Dr L S Mani
Chairman & Managing Director
Mumbai, 30th June, 2009
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article